Clinical Trial Update: Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease [Phase 4]

View source ↗

Summary

Clinical trial NCT01662414, sponsored by Chulalongkorn University, evaluated HMS 90 undenatured cysteine-rich whey protein isolate in Parkinson disease and has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Ganglia Diseases
• Brain Diseases
• Central Nervous System Diseases
• Movement Disorders
• Nervous System Diseases
• Neurodegenerative Diseases
• Parkinson Disease
• Parkinsonian Disorders

Drugs mentioned

• HMS 90 (undenatured cysteine-rich whey protein isolate)

Snippet

Sponsor: Chulalongkorn University | Conditions: Parkinson Disease, Parkinsonian Disorders | Phase 4 | Status: COMPLETED